{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:27:52Z","timestamp":1775816872238,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jaad.2013.08.034","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T17:15:22Z","timestamp":1382375722000},"page":"55-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Compliance with pregnancy prevention measures during isotretinoin therapy"],"prefix":"10.1016","volume":"70","author":[{"given":"Mary-Katharine","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline F.","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Opel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Swan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Prevost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Bimla Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Korb Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.08.034_bib1","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1371\/journal.pmed.0030483","article-title":"What is the best approach to reducing birth defects associated with isotretinoin?","volume":"3","author":"Abroms","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaad.2013.08.034_bib2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaad.2010.09.017","article-title":"The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system","volume":"65","author":"Shin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.034_bib3","unstructured":"Drug Safety and Risk Management Advisory Committee; Dermatologic and Opthalmic Drugs Advisory Committee. Briefing document for iPLEDGE. Available from: URL:http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/DermatologicandOphthalmicDrugsAdvisoryCommittee\/UCM281376.pdf. Accessed March 20, 2013."},{"key":"10.1016\/j.jaad.2013.08.034_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/2136191","article-title":"Measuring compliance among oral contraceptive users","volume":"28","author":"Potter","year":"1996","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.jaad.2013.08.034_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/OLQ.0b013e318225f8c3","article-title":"Baseline correlates of inconsistent and incorrect condom use among sexually active women in the contraceptive CHOICE project","volume":"38","author":"Shih","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2013.08.034_bib6","unstructured":"The iPLEDGE Program. Guide to best practices for the iPLEDGE\u00a0program, 2012. Available from: URL:https:\/\/www.ipledgeprogram.com\/Documents\/Guide%20to%20Best%20Practices%20-%20iPLEDGE%20Program.pdf. Accessed March 16, 2013."},{"key":"10.1016\/j.jaad.2013.08.034_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11606-011-1647-3","article-title":"The impact of contraceptive counseling in primary care on contraceptive use","volume":"26","author":"Lee","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jaad.2013.08.034_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2013.08.034_bib9","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.08.034_bib10","first-page":"338","article-title":"Pregnancy prevention among women taking isotretinoin: failure to comply with\u00a0the recommendations","volume":"52","author":"Boucher","year":"2006","journal-title":"Can Fam Physician"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:29:31Z","timestamp":1759271371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213009092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0190962213009092"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.08.034","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compliance with pregnancy prevention measures during isotretinoin therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}